Given its role in nucleotide synthesis and cell proliferation, ATCase activity has been investigated as a potential biomarker for cancer. Elevated levels of ATCase activity have been detected in several malignancies, including breast cancer, lung cancer, and colorectal cancer. Measuring ATCase activity in clinical samples could aid in the early detection and monitoring of these cancers.
